APA (7th ed.) Citation

S, C., IF, T., Ó, S., S, S., CJ, P., M, Á., . . . M, M. (2024). The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model. Paediatric drugs, 26(3), 331. https://doi.org/10.1007/s40272-024-00621-1

Chicago Style (17th ed.) Citation

S, Clemente-Bautista, et al. "The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model." Paediatric Drugs 26, no. 3 (2024): 331. https://doi.org/10.1007/s40272-024-00621-1.

MLA (9th ed.) Citation

S, Clemente-Bautista, et al. "The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model." Paediatric Drugs, vol. 26, no. 3, 2024, p. 331, https://doi.org/10.1007/s40272-024-00621-1.